Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
21.33
+0.29 (1.38%)
At close: Mar 9, 2026, 4:00 PM EDT
21.40
+0.07 (0.33%)
After-hours: Mar 9, 2026, 5:19 PM EDT
Immunome Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -212.39 | -292.96 | -106.81 | -36.9 | -24.71 | |
| Depreciation & Amortization | 2.96 | 2.1 | 0.73 | 0.63 | 0.76 | |
| Loss (Gain) From Sale of Assets | 0.9 | - | - | - | - | |
| Asset Writedown & Restructuring Costs | 10 | 152.34 | 80.8 | - | - | |
| Loss (Gain) From Sale of Investments | -2.84 | -2.9 | -0.51 | - | - | |
| Stock-Based Compensation | 25.69 | 15.75 | 6.22 | 5.33 | 3.45 | |
| Other Operating Activities | - | - | - | - | -0.5 | |
| Change in Accounts Payable | -9.16 | 9.53 | -0.61 | -0.68 | 1.78 | |
| Change in Unearned Revenue | -6.94 | -9.04 | 15.98 | - | - | |
| Change in Other Net Operating Assets | 0.88 | 14.39 | -3.38 | 2.92 | 1 | |
| Operating Cash Flow | -190.92 | -110.79 | -7.57 | -28.69 | -18.23 | |
| Capital Expenditures | -9.69 | -7.17 | -0.83 | -0.25 | -0.08 | |
| Cash Acquisitions | - | - | 9.28 | - | - | |
| Sale (Purchase) of Intangibles | -6.25 | -46.34 | - | - | - | |
| Investment in Securities | 76.73 | -31.56 | -38.93 | - | - | |
| Investing Cash Flow | 60.8 | -85.06 | -30.48 | -0.25 | -0.08 | |
| Long-Term Debt Repaid | - | - | - | - | -0.11 | |
| Net Debt Issued (Repaid) | - | - | - | - | -0.11 | |
| Issuance of Common Stock | 679.81 | 255.76 | 0.41 | 0.03 | 28.66 | |
| Other Financing Activities | -39.46 | -15.23 | 116 | - | -0.78 | |
| Financing Cash Flow | 640.36 | 240.53 | 116.41 | 0.03 | 27.77 | |
| Net Cash Flow | 510.24 | 44.67 | 78.36 | -28.91 | 9.46 | |
| Free Cash Flow | -200.6 | -117.97 | -8.4 | -28.94 | -18.31 | |
| Free Cash Flow Margin | -2890.13% | -1304.80% | -59.92% | - | - | |
| Free Cash Flow Per Share | -2.30 | -2.01 | -0.42 | -2.39 | -1.59 | |
| Cash Interest Paid | - | - | - | - | 0.01 | |
| Levered Free Cash Flow | -133.62 | -96.32 | -1.65 | -14.89 | -8.75 | |
| Unlevered Free Cash Flow | -133.62 | -96.32 | -1.65 | -14.89 | -8.74 | |
| Change in Working Capital | -15.23 | 14.87 | 12 | 2.24 | 2.78 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.